DeAngelo, Daniel J <br/><br/>
Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study.  [electronic resource] 

 -  Blood advances  Jun 2017 
 - 1167-1180 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2473-9529 
<br/><br/><label>Standard No.: </label>10.1182/bloodadvances.2016001925  doi